Your cart is empty
Browse transcripts and add items to get started.
Alpek delivered a strong operational quarter with comparable EBITDA of $150 million, up 50% sequentially and 19% year-over-year, driven by geopolitical-driven margin expansion in Polyester and volume recovery across both segments. Management now expects to reach or exceed the high end of its $550 million full-year EBITDA guidance range, though second-half visibility remains limited given ongoing Middle East supply disruptions.
Performance Highlights
Alpek reported first-quarter 2026 comparable EBITDA of $150 million, a 50% sequential and 19% year-over-year improvement that came in ahead of the company's own initial expectations. Total revenues reached $1.69 billion, roughly flat year-over-year, while reported EBITDA of $162 million surged 133% quarter-over-quarter, aided by a $23 million favorable inventory adjustment from rising raw material prices.
The single most important driver was the sharp recovery in Polyester segment margins, with Chinese PET reference margins averaging $246 per ton in March — up 41% sequentially and 44% year-over-year — as Middle East geopolitical tensions disrupted global petrochemical and feedstock flows. Supporting this, the Plastics and Chemicals segment delivered comparable EBITDA of $60 million, up 8% both sequentially and year-over-year on stronger polypropylene volumes, while the emerging Natural Gas business contributed an incremental $3–5 million from Gulf Coast winter storm pricing opportunities in January.
Management Outlook and Forward Catalysts
For the second quarter, management guided for comparable EBITDA of at least $200 million, citing Chinese PTA reference margins approaching $300 per ton, polypropylene spreads expanding by at least four cents per pound in April, and ocean freight costs to South America near $110 per metric ton. Based on this trajectory, Alpek indicated it expects to reach or exceed the high end of its full-year guidance range of $550 million, though it declined to formally revise guidance given uncertainty around the duration of Middle East supply disruptions.
The central investor debate heading into Q2 centres on how long elevated spreads persist and whether Alpek can translate this tailwind into durable deleveraging toward its 2.5x net debt-to-EBITDA target, currently at 3.9x. Bulls will watch for continued margin strength, $30–50 million in additional non-strategic asset sales in the second half, and the $20–30 million EBITDA uplift expected from the three-year $70 million polypropylene differentiated-products investment, while bears will focus on a potential rapid normalization of PET spreads once Middle East flows resume, working capital consumption from rising raw material prices, and execution risk at the Oman facility.
Adjusted EPS vs. consensus breakdown — primary performance driver, segment revenue contribution, and gross margin trajectory relative to prior guidance...
Segment-by-segment revenue analysis, margin profile, and management commentary on demand trajectory vs. consensus range expectations...
Forward guidance implications for the sector, supply chain read-throughs, and investment implications for the broader competitive landscape...